Table 4 Analysis of the impact of cardiovascular risk factors on the biomarkers of cellular and plasma hypercoagulability in patients with breast cancer
|  | Total population of patients (n = 62) | |
|---|---|---|
|  | CV RF (n = 21) | No CV RF (n = 41) |
MRI (mM/min) | 134 ± 51 | 167 ± 51 |
Peak (nM) | 317 ± 89 | 357 ± 72 |
ETP (mM.min) | 1490 ± 346 | 1552 ± 335 |
Pd-MP (/μL) | 8133 ± 6480 | 10955 ± 8893 |
Pd-MP/PS + (/μL) | 7896 ± 6328 | 10599 ± 8552 |
PPL (sec) | 42 ± 10 | 44 ± 11 |
D-dimers (ng/ml) | 1190 ± [440–1750] | 540 ± [280–830] |